Madison Paper Industries concluded the sale of its hydro power facilities in North America to Eagle Creek Renewable Energy

As one of the global leaders in electrotechnical paper manufacturing for insulation of high voltage cables and transformers, Ahlstrom-Munksjö plans to increase pulp production capacity and improve environmental performance of the Billingfors pulp line, Sweden. The investment involves rebuilding the recovery boiler and debottlenecking the pulp line. When completed in the third quarter 2019 the plant will meet stricter environmental regulations thanks to improved process combustion, reducing air emissions. Ahlstrom-Munksjö has also decided to modernize the bailing line at Aspa pulp plant, Sweden. The investment of EUR 4 million will improve safety level at the bailing line, improve production efficiency and give access to a more favorable customer mix. The new line is estimated to start during the first half of 2019. During the modernization production will continue normally. Click Read More below for additional information.

Vancive Medical Technologies™, an Avery Dennison business, and Eloquest Healthcare®, Inc. have partnered to develop an innovative post-operative dressing that contains an antimicrobial agent called chlorhexidine gluconate (CHG). The antimicrobial properties of CHG inhibit microbial growth within the dressing. CHG is extremely difficult to incorporate in an absorbent adhesive dressing, making the development of the BeneHold™ CHG platform a significant technical accomplishment for Vancive. The Eloquest Healthcare ReliaTect™ Post-Op Dressings with CHG are the first to combine CHG in an absorbent, transparent and waterproof design. Click Read More below for additional detail.

Executive Summary *First quarter 2021 net sales of $4.7 billion decreased 5 percent compared to the year-ago period, including an organic sales decline of 8 percent. *Diluted net income per share for the first quarter was $1.72 in 2021 and $1.92 in 2020. *First quarter adjusted earnings per share were $1.80 in 2021 compared to $2.13 in 2020. Adjusted earnings per share exclude certain items described later in this news release. *Diluted net income per share for 2021 is anticipated to be $6.65 to $7.15. *The company is now targeting full-year 2021 organic sales growth of 0 to 1 percent and adjusted earnings per share of $7.30 to $7.55. The prior outlook was for organic sales growth of 1 to 2 percent and adjusted earnings per share of $7.75 to $8.00. The updated earnings outlook reflects significantly higher input cost inflation and lower sales volumes, partially offset by higher net selling prices and additional cost savings.